Protective effects of baicalin on carbon tetrachloride induced liver injury by activating PPARγ and inhibiting TGFβ1

Pharmaceutical Biology

Volumn 49, Issue 1, 2011, Pages 38-45

  Qiao, Hongxiang ^a   Han, Hongcan ^a   Hong, Dongsheng ^a   Ren, Zihua ^a   Chen, Yan ^a   Zhou, Changxin ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

(PPAR ,); 1 (TGF ,1); Baicalin; Carbon tetrachloride (CCl4); Hepatic fibrosis; Peroxisome proliferator activated receptors ; Transforming growth factor

Indexed keywords

BAICALIN; CARBON TETRACHLORIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SILYMARIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DOWN REGULATION; DRUG MEGADOSE; DRUG POTENCY; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE ACTIVATION; GENE EXPRESSION; HEPATITIS; HISTOPATHOLOGY; LIVER INJURY; LIVER PROTECTION; LIVER TOXICITY; LOW DRUG DOSE; MALE; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CARBON TETRACHLORIDE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVONOIDS; GENE EXPRESSION REGULATION; LIVER CIRRHOSIS; LIVER DISEASES; MALE; MEDICINE, CHINESE TRADITIONAL; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; SILYMARIN; TRANSFORMING GROWTH FACTOR BETA1;

RATTUS;

EID: 78651337662     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2010.493179     Document Type: Article

References (39)

1. Alleva DG, Johnson EB, Lio FM, Boehme SA, Conlon PJ, Crowe PD. (2002). Regulation of murine macrophage proinfamma-tory and anti-infammatory cytokines by ligands for peroxisome proliferator-activated receptor-gamma: Counter-regulatory activity by IFN-gamma. J Leukoc Biol, 71, 677-685.
2. Bahcecioglu IH, Koca SS, Poyrazoglu OK, Yalniz M, Ozercan IH, Ustundag B, Sahin K, Dagli AF, Isik A. (2008). Hepatoprotective effect of infiximab, an anti-TNF-alpha agent, on carbon tetrachlo-ride-induced hepatic fbrosis. Infammation, 31, 215-221.
3. Bataller R, Brenner DA. (2005). Liver fbrosis. J Clin Invest, 115, 209-218.
4. Carpino G, Morini S, Ginanni Corradini S, Franchitto A, Merli M, Siciliano M, Gentili F, Onetti Muda A, Berloco P, Rossi M, Attili AF, Gaudio E. (2005). Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fbrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation. Dig Liver Dis, 37, 349-356.
5. Chang HJ, Lee JH, Hwang KJ, Kim MR, Chang KH, Park DW, Min CK. (2008). Transforming growth factor (TGF)-beta1-induced human endometrial stromal cell decidualization through extracellular signal-regulated kinase and Smad activation in vitro: Peroxisome proliferator-activated receptor gamma acts as a negative regulator of TGF-beta1. Fertil Steril, 90, 1357-1365.
6. Chung SW, Kang BY, Kim SH, Pak YK, Cho D, Trinchieri G, Kim TS. (2000). Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-gamma and nuclear factor-kappa B. J Biol Chem, 275, 32681-32687.
7. Evans RM. (1988). Te steroid and thyroid hormone receptor super-family. Science, 240, 889-895.
8. Friedman SL. (1999). Cytokines and fbrogenesis. Semin Liver Dis, 19, 129-140.
9. Friedman SL, Yamasaki G, Wong L. (1994). Modulation of transforming growth factor beta receptors of rat lipocytes during the hepatic wound healing response. Enhanced binding and reduced gene expression accompany cellular activation in culture and in vivo. J Biol Chem, 269, 10551-10558.
10. Fu Y, Zheng S, Lin J, Ryerse J, Chen A. (2008). Curcumin protects the rat liver from CCl4-caused injury and fbrogenesis by attenuating oxidative stress and suppressing infammation. Mol Pharmacol, 73, 399-409.
11. Galli A, Crabb D, Price D, Ceni E, Salzano R, Surrenti C, Casini A. (2000). Peroxisome proliferator-activated receptor gamma tran-scriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells. Hepatol-ogy, 31, 101-108.
12. Grasl-Kraupp B, Rossmanith W, Ruttkay-Nedecky B, Müllauer L, Kammerer B, Bursch W, Schulte-Hermann R. (1998). Levels of transforming growth factor beta and transforming growth factor beta receptors in rat liver during growth, regression by apoptosis and neoplasia. Hepatology, 28, 717-726.
13. Gressner AM, Weiskirchen R. (2006). Modern pathogenetic concepts of liver fbrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med, 10, 76-99.
14. Gressner OA, Lahme B, Rehbein K, Siluschek M, Weiskirchen R, Gressner AM. (2008). Pharmacological application of cafeine inhibits TGF-beta-stimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-depen-dent pathways. J Hepatol, 49, 758-767.
15. Jeong HG. (1999). Inhibition of cytochrome P450 2E1 expression by oleanolic acid: Hepatoprotective effects against carbon tetrachlo-ride-induced hepatic injury. Toxicol Lett, 105, 215-222.
16. Jiang C, Ting AT, Seed B. (1998). PPAR-gamma agonists inhibit production of monocyte infammatory cytokines. Nature, 391, 82-86.
17. Kawai T, Masaki T, Doi S, Arakawa T, Yokoyama Y, Doi T, Kohno N, Yorioka N. (2009). PPAR-gamma agonist attenuates renal interstitial fbrosis and infammation through reduction of TGF-beta. Lab Invest, 89, 47-58.
18. Lee SJ, Yang EK, Kim SG. (2006). Peroxisome proliferator-activated receptor-gamma and retinoic acid X receptor alpha represses the TGFbeta1 gene via PTEN-mediated p70 ribosomal S6 kinase-1 inhibition: Role for Zf9 dephosphorylation. Mol Pharmacol, 70, 415-425.
19. Li D, Friedman SL. (1999). Liver fbrogenesis and the role of hepatic stellate cells: New insights and prospects for therapy. J Gastroen-terol Hepatol, 14, 618-633.
20. Liu LL, Gong LK, Wang H, Xiao Y, Wu XF, Zhang YH, Xue X, Qi XM, Ren J. (2007). Baicalin protects mouse from concanavalin A-in-duced liver injury through inhibition of cytokine production and hepatocyte apoptosis. Liver Int, 27, 582-591.
21. Liu X, Wang W, Hu H, Tang N, Zhang C, Liang W, Wang M. (2006). SMAD3 specific inhibitor, naringenin, decreases the expression of extracellular matrix induced by TGF-beta1 in cultured rat hepatic stellate cells. Pharm Res, 23, 82-89.
22. Meindl-Beinker NM, Dooley S. (2008). Transforming growth factor-beta and hepatocyte transdiferentiation in liver fbrogenesis. J Gastroenterol Hepatol, 23, S122-127.
23. Miyahara T, Schrum L, Rippe R, Xiong S, Yee HF Jr, Motomura K, Anania FA, Willson TM, Tsukamoto H. (2000). Peroxisome prolif-erator-activated receptors and hepatic stellate cell activation. J Biol Chem, 275, 35715-35722.
24. Orfla C, Lepert JC, Alric L, Carrera G, Béraud M, Pipy B. (2005). Immunohistochemical distribution of activated nuclear factor kappaB and peroxisome proliferator-activated receptors in carbon tetrachloride-induced chronic liver injury in rats. Histochem Cell Biol, 123, 585-593.
25. Oyagi S, Hirose M, Kojima M, Okuyama M, Kawase M, Nakamura T, Ohgushi H, Yagi K. (2006). Terapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured rats. J Hepatol, 44, 742-748.
26. Park SW, Lee CH, Kim YS, Kang SS, Jeon SJ, Son KH, Lee SM. (2008). Protective effect of baicalin against carbon tetrachloride-induced acute hepatic injury in mice. J Pharmacol Sci, 106, 136-143.
27. Recknagel RO, Glende EA Jr, Dolak JA, Waller RL. (1989). Mechanisms of carbon tetrachloride toxicity. Pharmacol Ter, 43, 139-154.
28. Roberts AB, Russo A, Felici A, Flanders KC. (2003). SMAD3: A key player in pathogenetic mechanisms dependent on TGF-beta. Ann N Y Acad Sci, 995, 1-10.
29. Sakaida I, Matsumura Y, Kubota M, Kayano K, Takenaka K, Okita K. (1996). Te prolyl 4-hydroxylase inhibitor HOE 077 prevents activation of Ito cells, reducing procollagen gene expression in rat liver fbrosis induced by choline-defcient l-amino acid-defned diet. Hepatology, 23, 755-763.
30. Sanderson N, Factor V, Nagy P, Kopp J, Kondaiah P, Wakefeld L, Roberts AB, Sporn MB, Torgeirsson SS. (1995). Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA, 92, 2572-2576.
31. Simeonova PP, Gallucci RM, Hulderman T, Wilson R, Kommineni C, Rao M, Luster MI. (2001). Te role of tumor necrosis factor-alpha in liver toxicity, infammation, and fbrosis induced by carbon tet-rachloride. Toxicol Appl Pharmacol, 177, 112-120.
32. Kershenobich Stalnikowitz D, Weissbrod AB. (2003). Liver fbrosis and infammation. Ann Hepatol, 2, 159-163.
33. Straus DS, Pascual G, Li M, Welch JS, Ricote M, Hsiang CH, Sengchanthalangsy LL, Ghosh G, Glass CK. (2000). 15-Deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc Natl Acad Sci, 97, 4844-4849.
34. Tsai JH, Liu JY, Wu TT, Ho PC, Huang CY, Shyu JC, Hsieh YS, Tsai CC, Liu YC. (2008). Efects of silymarin on the resolution of liver fbrosis induced by carbon tetrachloride in rats. J Viral Hepat, 15, 508-514.
35. Wan JY, Gong X, Zhang L, Li HZ, Zhou YF, Zhou QX. (2008). Protective effect of baicalin against lipopolysaccharide/d-galactosamine-induced liver injury in mice by up-regulation of heme oxygenase-1. Eur J Pharmacol, 587, 302-308.
36. Yokogawa K, Watanabe M, Takeshita H, Nomura M, Mano Y, Miyamoto K. (2004). Serum aminotransferase activity as a predictor of clearance of drugs metabolized by CYP isoforms in rats with acute hepatic failure induced by carbon tetrachloride. Int J Pharm, 269, 479-489.
37. Zhao C, Chen W, Yang L, Chen L, Stimpson SA, Diehl AM. (2006). PPAR-gamma agonists prevent TGFbeta1/SMAD3-signaling in human hepatic stellate cells. Biochem Biophys Res Commun, 350, 385-391.
38. Zhao Y, Li H, Gao Z, Xu H. (2005). Efects of dietary baicalin supplementation on iron overload-induced mouse liver oxidative injury. Eur J Pharmacol, 509, 195-200.
39. Zheng S, Chen A. (2006). Curcumin suppresses the expression of extracellular matrix genes in activated hepatic stellate cells by inhibiting gene expression of connective tissue growth factor. Am J Physiol Gastrointest Liver Physiol, 290, G883-893.